Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review

Author： Marson A.G. Hutton J.L. Leach J.P. Castillo S. Schmidt D. White S. Chaisewikul R. Privitera M. Chadwick D.W.

Publisher： Elsevier

ISSN： 0920-1211

Source： Epilepsy Research, Vol.46, Iss.3, 2001-09, pp. : 259-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levetiracetam monotherapy for adults with localization-related epilepsy

By Alsaadi T.M. Thieman C. Zusman E.E.

Epilepsy & Behavior, Vol. 3, Iss. 5, 2002-10 ,pp. : 471-474

Elsevier

Access to resources Recommend Favorite

Ictal hypoxemia in localization-related epilepsy: analysis of incidence, severity and risk factors

By Bateman Lisa M.

Brain, Vol. 131, Iss. 12, 2008-12 ,pp. : 3239-3245

Oxford University Press

Access to resources Recommend Favorite

A systematic review of the safety profile of levetiracetam: a new antiepileptic drug

By French J. Edrich P. Cramer J.A.

Epilepsy Research, Vol. 47, Iss. 1, 2001-11 ,pp. : 77-90

Elsevier

Access to resources Recommend Favorite

Drug review - Levetiracetam

By Bull Eleanor

Drugs In Context Primary Care Part C: Psychiatry and Neurology, Vol. 1, Iss. 6, 2004-12 ,pp. : 268-283

CSF Medical Communications Ltd

Access to resources Recommend Favorite

A comparison of the neuropathological effects of vigabatrin and carbamazepine in patients with newly diagnosed localization-related epilepsy using MR-based cerebral T2 relaxation time measurements

By Van Paesschen W. Duncan J.S. Connelly A.

Epilepsy Research, Vol. 29, Iss. 2, 1998-01 ,pp. : 155-160

Elsevier

Access to resources Recommend Favorite